Evidence map›Paper›PMID 41158138›Full record

ArticleExperimental and therapeutic medicine2025

Effects of disaccharide and cationic lipid types on reverse transfection with lyophilized mRNA lipoplexes.

Ryohei Shimizu, Yoshiyuki Hattori

Abstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ryohei ShimizuDepartment of Molecular Pharmaceutics, Hoshi University, Shinagawa, Tokyo 142-8501, Japan.
Yoshiyuki HattoriDepartment of Molecular Pharmaceutics, Hoshi University, Shinagawa, Tokyo 142-8501, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, the development of messenger RNA (mRNA) therapeutics has received increased attention, and mRNA/cationic liposome complexes (mRNA lipoplexes) have been studied as effective mRNA delivery carriers. However, owing to the vast diversity of the mRNA and carrier components employed, establishing a comprehensive analysis of their efficacy remains a critical issue. Reverse transfection using lyophilized mRNA lipoplexes has the potential to simplify and automate the efficacy evaluation processes. The present study investigated the effects of cationic lipids in cationic liposomes and disaccharides as cryoprotectants during reverse transfection with lyophilized mRNA lipoplexes. Overall, five types of dialkyl or trialkyl cationic lipids were used to prepare cationic liposomes. The mRNA lipoplexes were lyophilized in the presence of trehalose or sucrose in multi-well plates. An increase in the concentration of the disaccharide solution during the lyophilization of mRNA lipoplexes enhanced the transfection activity. Furthermore, mRNA lipoplexes lyophilized in 150 mM sucrose solution exhibited long-term stability for up to 1 month. The transfection activity of mRNA lipoplexes composed of dialkyl cationic lipids was largely unaffected by lyophilization, whereas a significant reduction in transfection activity was observed for mRNA lipoplexes composed of trialkyl cationic lipids. These findings suggest that although dependent on the lipid type used for the preparation of cationic liposomes, the reverse transfection method using lyophilized mRNA lipoplexes has the potential to be applied for screening the transfection efficiency of mRNA lipoplexes and the function of proteins translated from mRNA.

Indexed as

cationic lipidlipoplexeslyophilizationmRNA deliveryreverse transfection

Identifiers

PMID41158138
PMCPMC12555113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.